S&P 500 Futures
(0.09%) 5 332.00 points

Dow Jones Futures
(0.02%) 40 144 points

Nasdaq Futures
(0.14%) 18 661 points

Oil
(-0.06%) $80.01

Gas
(0.53%) $2.64

Gold
(1.09%) $2 443.70

Silver
(2.80%) $32.14

Platinum
(0.34%) $1 093.70

USD/EUR
(-0.02%) $0.920

USD/NOK
(-0.05%) $10.67

USD/GBP
(0.03%) $0.787

USD/RUB
(-0.79%) $90.25

Realtime updates for Kronos Bio, Inc. [KRON]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

3.89% $ 1.020

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity...

Stats
Today's Volume	249 632
Average Volume	429 974
Market Cap	61.30M
EPS	$0 ( 2024-05-08 )
Next earnings date	( $-0.410 ) 2024-06-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.520
ATR14	$0.00600 (0.60%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-21	Olek Elizabeth A	Sell	7 368	Common Stock
2024-02-16	Olek Elizabeth A	Sell	0	Common Stock
2024-02-16	Olek Elizabeth A	Sell	89 120	Stock Option (Right to Buy)
2024-02-16	Olek Elizabeth A	Sell	145 795	Stock Option (Right to Buy)
2024-02-16	Olek Elizabeth A	Sell	87 500	Stock Option (Right to Buy)

INSIDER POWER
44.61
Last 97 transactions
Buy: 7 377 688 \| Sell: 1 665 671

Volume Correlation

Long: 0.28 (neutral)

Short: 0.13 (neutral)

Signal:(39.909) Neutral

Kronos Bio, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kronos Bio, Inc. Correlation - Currency/Commodity

0.13
( neutral )

-0.36
( neutral )

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

-0.39
( neutral )

Kronos Bio, Inc. Financials

Annual	2023
Revenue:	$6.29M
Gross Profit:	$1.37M (21.82 %)
EPS:	$-1.950

FY	2023
Revenue:	$6.29M
Gross Profit:	$1.37M (21.82 %)
EPS:	$-1.950

FY	2022
Revenue:	$0
Gross Profit:	$-4.46M (0.00 %)
EPS:	$-2.30

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.79

Financial Reports:

No articles found.

Kronos Bio, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Kronos Bio, Inc.

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The company planned registrational phase 3 clinical trial of ENTO in combination with induction chemotherapy in acute myeloid leukemia patients with NPM1 mutations. It is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in San Mateo, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.